| CYSB2400140 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| JYSB1600202 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2016-10-20 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2017-03-27 | view |
| JYSB2101113 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-08-26 | | Sanofi-Aventis Deutschland GmbH | | | view |
| CXSL1200109 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2013-02-19 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2014-06-17 | view |
| CYSB2100018 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-11 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2022-01-19 | view |
| JYSB2000608 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-11-16 | view |
| JYSZ1800019 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2018-07-27 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2019-03-01 | view |
| CYSB2300078 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-04-05 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL1400035 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2014-04-28 | 宜昌长江药业有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | Certificate Issued | 2016-08-01 | view |
| CYSB2101083 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-06-03 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JYSB0900098 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2009-05-27 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2009-12-15 | view |
| CYSB2000379 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-23 | 赛诺菲（北京）制药有限公司 | Sanofi (Beijing) Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-18 | view |
| AS20000032 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | New Drug Application | 2000-10-31 | 安万特（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| JXSS1900030 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Import Drug Application | 2019-06-12 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2020-09-04 | view |
| JYSB2400079 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-04-08 | | | | | view |
| CXSL1600006 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2016-03-17 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2017-01-11 | view |
| CYSB2200117 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2022-05-18 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSL1200027 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2012-05-17 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2013-01-30 | view |
| JXSS2000064 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Import Drug Application | 2020-12-23 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | In Review | 2021-05-09 | view |
| JYSB2000254 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-06-18 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Filed | 2020-06-19 | view |
